Background: Inflammation influences cancer development and progression. An elevated
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …

Background Inflammation biomarkers have been introduced into clinical practice for risk-
rating in treatment of patients with cancer. We aimed to confirm the prognostic role of platelet …

Background Recently, more and more studies investigated the association of inflammation
parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various …

Many studies have been reported that platelet–lymphocyte ratio (PLR) may be associated
with the prognosis of colorectal cancer (CRC), but the results are inconsistent. Current …

Platelet to lymphocyte ratio (PLR) was recently reported as a useful index in predicting the
prognosis of lung cancer. However, the prognostic role of PLR in lung cancer remains …

Platelet-lymphocyte ratio (PLR) is a hematological parameter which is investigated as a
biomarker for prognosis in patients with breast cancer. Due to the controversial results from …

Background Conflicting evidence exists regarding the effects of platelet/lymphocyte ratio
(PLR) and lymphocyte/monocyte ratio (LMR) on the prognosis of colorectal cancer (CRC) …

Background. We aimed to evaluate the correlation of platelet‐to‐lymphocyte ratio (PLR) with
prognosis and clinicopathological characteristics of breast cancer. Methods. The PubMed …

Objectives Recent studies suggest that an elevated preoperative platelet to lymphocyte ratio
(PLR) may be considered a poor prognostic biomarker in patients with colorectal cancer …

Background This study aimed to summarize the previously published literature on the role of
platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients with gastric cancer …